Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant

Leukemia and Lymphoma

Volumn 52, Issue 8, 2011, Pages 1556-1566

  Wang, Yi ^a,b   Chen, Guanghua ^a   Qiao, Shumin ^a   Ma, Xiao ^a   Tang, Xiaowen ^a   Sun, Aining ^a   Wu, Depei ^a  

^a BEIJING HOSPITAL   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

graft versus leukemia; immune reconstitution; keratinocyte growth factor; murine model; Umbilical cord blood transplant

Indexed keywords

KERATINOCYTE GROWTH FACTOR; RECOMBINANT KERATINOCYTE GROWTH FACTOR; SODIUM CHLORIDE; T LYMPHOCYTE RECEPTOR; THROMBOCYTE CONCENTRATE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGENEIC UMBILICAL CORD BLOOD CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; ERYTHROLEUKEMIA; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT VERSUS HOST LEUKEMIA; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPHOCYTE SUBPOPULATION; MOUSE; MYELOABLATIVE CONDITIONING; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; SURVIVAL RATE; T LYMPHOCYTE; THYMOPOIESIS; THYMUS FUNCTION; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ANIMALS; CELL LINE, TUMOR; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FIBROBLAST GROWTH FACTOR 7; GRAFT SURVIVAL; KAPLAN-MEIER ESTIMATE; KILLER CELLS, NATURAL; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; NEOPLASM TRANSPLANTATION; PLATELET TRANSFUSION; PREGNANCY; SPLEEN; T-LYMPHOCYTES; THYMECTOMY; THYMUS GLAND; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 79960401703     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.573037     Document Type: Article

References (42)

1. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica 2009;94:451-454
2. Frassoni F, Gualandi F, Podestà M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008;9:831-839
3. Broxmeyer HE. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 2005;7: 209-218 (Pubitemid 41051363)
4. Komanduri KV, John LS, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007;110:4543-4551 (Pubitemid 351377822)
5. Szabolcs P, Niedzwiecki D. Immune reconstitution in children after unrelated cord blood transplantation. Biol Blood Marrow Transplant 2008;14:66-72 (Pubitemid 350286846)
6. Takami A, Mochizuki K, Asakura H, et al. High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematologica 2005;90: 1290-1292 (Pubitemid 41375297)
7. Migishima F, Oikawa A, Kondo S, et al. Full reconstitution of hematopoietic system by murine umbilical cord blood. Transplantation 2003;75:1820-1826 (Pubitemid 36734637)
8. Chen BJ, Cui X, Sempowski GD, et al. A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. Blood 2002;99:364-731
9. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-491 (Pubitemid 38140078)
10. Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008;112:4318-4327
11. Nash RA, Gooley T, Davis C, et al. The problem of thrombocytopenia after hematopoietic stem cell transplantation. Oncologist 1996;1:371-380 (Pubitemid 126669246)
12. Anderson G, Lane PJ, Jenkinson EJ. Generating intrathymic microenvironments to establish T-cell tolerance. Nat Rev Immunol 2007;7:954-963 (Pubitemid 350166055)
13. Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002;99:4592-4600 (Pubitemid 34627232)
14. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol 2003;21:139-176 (Pubitemid 37174529)
15. Rossi S, Blazar BR, Farrell CL, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 2002;100:682-691 (Pubitemid 34761136)
16. Rossi SW, Jeker LT, Ueno T, et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 2007;109:3803-3811 (Pubitemid 46641731)
17. Panoskaltsis-Mortari A, Lacey DL, Vallera DA, Blazar BR. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 1998;92:3960-3967 (Pubitemid 28525223)
18. Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002;99:1458-1464 (Pubitemid 34547105)
19. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-695 (Pubitemid 29003949)
20. Krenger W, Schmidlin H, Cavadini G, Holla?nder GA. On the relevance of TCR rearrangement circles as molecular markers for thymic output during experimental graft-versus-host disease. J Immunol 2004;172:7359-7367 (Pubitemid 38747596)
21. Chen G, Wu D, Wang Y, et al. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Eur J Haematol 2008;81: 226-235
22. Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996;88:3230-3239 (Pubitemid 26357409)
23. Broers A, Sluijs SJ, Spits H, et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 2003;102: 1534-1540 (Pubitemid 36988068)
24. Li YQ, Chen SH, Yang LJ, et al. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transplant Immunol 2007;18:151-158
25. Miller JS, Weisdorf DJ, Burns LJ, et al. Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone. Blood 2007;110:2761-2763 (Pubitemid 47523203)
26. Dodero A, Carniti C, Raganato A, et al. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery. Blood 2009;113: 4771-4779
27. Marks DI, Lush R, Cavenagh J, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 2002;100:3108-3114 (Pubitemid 35217056)
28. Solomon SR, Mielke S, Savani BN, et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 2005;106:1123-1129 (Pubitemid 41076463)
29. Wagner JE, Gluckman E. Umbilical cord blood transplantation: the first 20 years. Semin Hematol 2010;47:3-12
30. Reddy P, Negrin R, Hill GR. Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant 2008;14: 129-135 (Pubitemid 350286851)
31. Patel SR, Cadwell CM, Medford A, Zimring JC. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest 2009;119:2787-2794
32. Duran-Struuck R, Dysko RC. Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci 2009;48:11-22
33. Ooi J, Iseki T, Takahashi S, et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol 2002;118:140-143 (Pubitemid 34779528)
34. Frangoulis B, Besluau D, Chopin M, Degos L, Pla M. Immune response to H-2 class I antigens on platelets. I. Immunogenicity of platelet class I antigens. Tissue Antigens 1988;32:46-54
35. Bernstein ID, Boyd RL, van den Brink M. Clinical strategies to enhance posttransplant immune reconstitution. Biol Blood Marrow Transplant 2008;14:94-99 (Pubitemid 350286838)
36. Seggewiss R, Loré K, Guenaga FJ, et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 2007;110:441-449 (Pubitemid 47026867)
37. Krijanovski OI, Hill GR, Cooke KR, et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood 1999;94:825-831 (Pubitemid 29323898)
38. Alpdogan Ö, Hubbard VM, Smith OM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 2006;107:2453-2460 (Pubitemid 43345567)
39. Kelly RM, Goren EM, Taylor PA, et al. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood 2010; 115:1088-1097
40. Kelly RM, Highfill SL, Panoskaltsis-Mortari A, et al. Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood 2008;111: 5734-5744
41. Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996;156: 4609-4616 (Pubitemid 26174440)
42. Jenq RR, King CG, Volk C, et al. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood 2009;113: 1574-1580